Instruments

Name Stock exchange Average volume Price Type
JOHNSON & JOHNSON JNJ

Nyse +17 Other

7,354,561 154.6 USD Stock Johnson & Johnson Stock
JOHNSON & JOHNSON 000943981

Berne S.E.

- 140 CHF Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Deutsche Boerse AG

929 141.9 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ *

Mexican S.E.

1,197 2,568 MXN Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Swiss Exchange

- 136 USD Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Frankfurt

3,193 141.5 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Wiener Boerse

32 141.6 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON 0R34

London S.E.

1,193 149.3 USD Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Börse Stuttgart

566 142.2 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Bolsa De Valores De Colombia

23 5,89,000 COP Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Lima

- 144.5 USD Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Santiago S.E.

- 148.3 USD Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

BOERSE MUENCHEN

2,617 142.2 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON 4JNJ

Borsa Italiana

- 139.6 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Bulgaria S.E.

6 138.7 EUR Stock Johnson & Johnson
JOHNSON & JOHNSON JNJCL

Santiago S.E.

- 1,55,930 CLP Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ_KZ

Kazakhstan S.E.

13 155 USD Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Swiss Exchange

- 500 CHF Stock Johnson & Johnson
JOHNSON & JOHNSON JNJ

Buenos Aires S.E. +1 Other

10,565 11,386 ARS Stock Johnson & Johnson Stock
JOHNSON & JOHNSON JNJD

Buenos Aires S.E.

569 10.9 USD Stock Johnson & Johnson
JOHNSON & JOHNSON JNJB34

Sao Paulo

6,541 52.45 BRL Stock Johnson & Johnson Stock
JOHNSON & JOHNSON JNJ0

Deutsche Boerse AG +1 Other

- 13.5 EUR Stock Johnson & Johnson Stock
JOHNSON & JOHNSON JNJ

NEO Exchange

9,822 20.71 CAD Stock Johnson & Johnson
JOHNSON CONTROLS INTERNATIONAL PLC JCI

Nyse +7 Other

6,209,235 69.02 USD Stock Johnson Controls International Plc Stock
JOHNSON CONTROLS INTERNATIONAL PLC TYIA

Deutsche Boerse AG

112 62.55 EUR Stock Johnson Controls International Plc
JOHNSON CONTROLS INTERNATIONAL PLC JCI1 N

Mexican S.E.

0 1,120 MXN Stock Johnson Controls International plc
JOHNSON CONTROLS INTERNATIONAL PLC 0Y7S

London S.E.

16 67.13 USD Stock Johnson Controls International Plc
JOHNSON CONTROLS INTERNATIONAL PLC TYIA

Börse Stuttgart

- 63.43 EUR Stock Johnson Controls International Plc
JOHNSON CONTROLS INTERNATIONAL PLC TYIA

BOERSE MUENCHEN

112 63.32 EUR Stock Johnson Controls International Plc
JOHNSON CONTROLS INTERNATIONAL PLC TYIA

Frankfurt

22 53.62 EUR Stock Johnson Controls International Plc
JOHNSON CONTROLS INTERNATIONAL PLC TYIA

Berne S.E.

- - CHF Stock Johnson Controls International Plc
JOHNSON OUTDOORS INC. JOUT

Nasdaq

73,401 36.94 USD Stock Johnson Outdoors Inc. Stock
PRISM JOHNSON LIMITED PRSMJOHNSN

Bombay S.E. +1 Other

29,958 143.8 INR Stock Prism Johnson Limited Stock
PRISM JOHNSON LIMITED PRSMJOHNSN

NSE India S.E.

464,319 143.6 INR Stock Prism Johnson Limited
JOHNSON MATTHEY PLC JMPLY

OTC Markets

997 46.93 USD Stock Johnson Matthey Plc Stock
JOHNSON PHARMACARE LIMITED SUNSHINE6

Bombay S.E.

1,645,392 1.1 INR Stock Johnson Pharmacare Limited Stock
JOHNSON MATTHEY PLC JMAT

London S.E. +6 Other

298,212 1,845 GBX Stock Johnson Matthey Plc Stock
JOHNSON MATTHEY PLC JMT2

Deutsche Boerse AG

- 21.1 EUR Stock Johnson Matthey Plc
JOHNSON MATTHEY PLC JMAT N

Mexican S.E.

- 811 MXN Stock Johnson Matthey Plc
JOHNSON MATTHEY PLC JMT2

Börse Stuttgart

- 21.24 EUR Stock Johnson Matthey Plc
JOHNSON MATTHEY PLC JMT2

BOERSE MUENCHEN

- 21.72 EUR Stock Johnson Matthey Plc
JOHNSON MATTHEY PLC JMPLF

OTC Markets

904 23.3 USD Stock Johnson Matthey Plc
JOHNSON MATTHEY PLC JMAT

Berne S.E.

- - CHF Stock Johnson Matthey Plc

News (1204)

Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update AQ
Transcript : Portillo's Inc., Q1 2024 Earnings Call, May 07, 2024
Transcript : Jazz Pharmaceuticals plc, Q1 2024 Earnings Call, May 01, 2024
Transcript : Woodside Energy Group Ltd - Shareholder/Analyst Call
Letshego Africa : Notice of Unclaimed Dividends PU
Transcript : Darden Restaurants, Inc., Q3 2024 Earnings Call, Mar 21, 2024
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer BU
Transcript : Alpine Immune Sciences, Inc., 2023 Earnings Call, Mar 18, 2024
Financial Statement January 1 to December 31 2023 AQ
Faron’s Financial Statement Release January 1 to December 31, 2023 AQ
Qualcomm : 2024 voting results PU
Transcript : Lancashire Holdings Limited, Q4 2023 Earnings Call, Mar 06, 2024
Heidrick & Struggles Announces Promotions of Partners, Principals, and Senior Client Principals across Executive Search, Heidrick Consulting, and On-Demand Talent Businesses PR
Transcript : Jazz Pharmaceuticals plc, Q4 2023 Earnings Call, Feb 28, 2024
Transcript : Hargreaves Lansdown plc, H1 2024 Earnings Call, Feb 22, 2024
Transcript : Yum! Brands, Inc., Q4 2023 Earnings Call, Feb 07, 2024
Transcript : Kromek Group plc, H1 2024 Earnings Call, Jan 31, 2024
Health Care Service Corporation, a Mutual Legal Reserve Company entered into an agreement to acquire Medicare Advantage, Cigna Supplemental Benefits and CareAllies Businesses from The Cigna Group (NYSE:CI) for $3.3 billion CI
2seventy bio Announces New Strategic Path Forward BU
Advent Technologies Announces Appointment of Naiem Hussain as Chief Financial Officer BU
Walmart settles lawsuit over refusal to promote mother of young children RE
Pembina Pipeline : Offering of Subscription Receipts of Pembina Pipeline Corporation - Form 6-K PU
Transcript : Darden Restaurants, Inc., Q2 2024 Earnings Call, Dec 15, 2023
Merck and Eisai Provide Update on Phase 3 LEAP-001 Trial Evaluating (pembrolizumab) Plus LENVIMA® (lenvatinib) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma BU
RTX Announces New Lead Independent Director PR
Transcript : Lancashire Holdings Limited, Q3 2023 Sales/ Trading Statement Call, Nov 09, 2023
Transcript : Alpine Immune Sciences, Inc. - Special Call
PlantX Welcomes Meek's Vegan Pizza to Chicago Foodhall Lineup CI
Solarvest BioEnergy Inc. Announces Board Changes CI
SOLARVEST ANNOUNCES WITHDRAWAL OF SHAREHOLDER REQUISITION AND DIRECTOR CHANGES AQ
Inotiv, Inc. Announces Changes to its Board Composition AQ
European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults With Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy BU
CACI Board Director Gregory G. Johnson Named to NACD Directorship 100 BU
Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2023 AQ
The Arbitrability Of Non-Sexual Harassment Claims Under The "Ending Forced Arbitration Of Sexual Harassment And Sexual Assault Act" AQ
Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2023 AQ
Botswana Insurance : NOTICE TO SHAREHOLDERS - UNCLAIMED DIVIDENDS PU
Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Patients With Certain Types of Metastatic Non-Small Cell Lung Cancer BU
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy BU
Tonix Pharmaceuticals Announces Topline Results from Phase 2 PREVAIL Proof-of-Concept Study of TNX-102 SL for the Management of Fibromyalgia-Type Long COVID AQ
Catalent Announces Governance Enhancements and New Initiatives to Drive Value BU
Merck and Eisai Provide Update on Phase 3 LEAP-010 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Patients With Certain Types of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma BU
Southern BancShares N C : Quarterly Report – June 2023 PU
UK Gilt Yields Fall After Weaker-Than-Expected Retail Sales Data DJ
Transcript : The Wendy's Company, Q2 2023 Earnings Call, Aug 09, 2023
1234NextSee all

Companies (51)

JOHNSON & JOHNSON 371 B $
Logo Johnson & Johnson

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...

JOHNSON & JOHNSON 371 B $
Logo Johnson & Johnson

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...

JOHNSON & JOHNSON 371 B $
Logo Johnson & Johnson

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...

JOHNSON & JOHNSON 371 B $
Logo Johnson & Johnson

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...

ROYALTY PHARMA PLC 12 573 M $
Logo Royalty Pharma plc

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-ca ...

ALLEGION PLC 10 964 M $
Logo Allegion plc

Allegion plc specializes in manufacturing and marketing security systems. Products are sold under the Cisa, Interflex, LCN, Schlage, Von Duprin, Aptiq, Bocom, Briton, Bricard, Dexter, Falcon, Glynn-Johnson, Ito Kilit, Ives, Kryptonite, Legge, Normbau, Ste ...

HEAVY MINERALS LIMITED 3 M $
Logo Heavy Minerals Limited

Heavy Minerals Limited is an Australia-based industrial mineral exploration company. The Company’s projects are prospective for industrial minerals including Garnet, Zircon, Rutile and Ilmenite. Its projects consist of Port Gregory Garnet project, Red H ...

KENVUE INC. 43 201 M $
Logo Kenvue Inc.

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: ...

JOHNSON CONTROLS INTERNATIONAL PLC 45 992 M $
Logo Johnson Controls International Plc

Johnson Controls International Plc specializes in the design, manufacturing and marketing of equipment for the regulation and safety of buildings. Net sales break down by family of products and services as follows: - building regulation, integrated manag ...

PRISM JOHNSON LIMITED 902 M $
Logo Prism Johnson Limited

Prism Johnson Limited is an India-based building materials company. The Company operates through four segments: Cement, Tile and Bath (HRJ), and Ready Mixed Concrete (RMC). The Cement segment has a cement production capacity of 5.6-meganewton tons at Satn ...


1234Next

Insiders

Picture Gregory Johnson
Gregory Johnson

Gregory Johnson is currently working as a Logistics Analyst at AFMS Logistics Management Group LLC since 2004.
He completed his undergraduate degree from the State University of New York at Albany.





Picture Gregory Johnson
Gregory Johnson

Gregory N.
Johnson
is currently the President & Chief Executive Officer at McAfee Corp.
and an Independent Director at QUALCOMM, Inc. He is also the Vice President-Manufacturing at Royal Vendors, Inc. In the past, Mr. Johnson held positions such as SVP-Marketing, Strategy & Communications at Best Buy Co., Inc., Vice President-Marketing & International Markets at Gillette Co., and Executive Vice President & GM-Consumer Group at Intuit, Inc. He also worked as a Principal at Eastman Kodak Co., Motorola, Inc., and Mondelez International, Inc. Additionally, he served as the Senior Vice President-Market Strategy at Advance Auto Parts, Inc. and held a position at S.C.
Johnson & Son, Inc.Mr. Johnson completed his undergraduate degree at the United States Air Force Academy.


Picture Gregory K. Johnson
Gregory K. Johnson

Gregory K.
Johnson
is associated with Wright Runstad Associates LP since 2001 and currently holds the position of President.


Picture Greg Johnson
Greg Johnson

Gregory Keith Johnson has worked as a Vice President & Wealth Consultant at Bell Bank in Fargo, North Dakota since 2005.


Picture Gregory Johnson
Gregory Johnson

Gregory Johnson currently works at Hayes & Associates LLC, as CFO & Director-Accounting Services, Institute of Management Accountants, Inc., as Member, National Society of Accountants, as Member, and Nothing But Net Foundation, Inc., as Treasurer.



Picture Gregory Johnson
Gregory Johnson

Gregory Shawn Johnson is the founder of NovaGold Resources, Inc. (founded in 1984).
He is currently the Chairman & Chief Executive Officer at Metallic Minerals Corp.
(since 2016) and the Executive Chairman at Stillwater Critical Minerals Corp.
(since 2017).
Previously, he held positions such as President, Chief Executive Officer & Director at Gold Springs Resource Corp.
(2009-2012), President, Chief Executive Officer & Director at Nickel Creek Platinum Corp.
(2012-2015), Independent Director at TNR Gold Corp.
(2012-2021), Lead Independent Director at Triumph Gold Corp.
(2008-2017), and Independent Director at Namibia Critical Metals, Inc. (2010-2013).
Mr. Johnson obtained his undergraduate degree from Western Washington University in 1989.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW